Author
Listed:
- Shinya Rai
(Kindai University Faculty of Medicine)
- Hirokazu Tanaka
(Kindai University Faculty of Medicine)
- Mai Suzuki
(National Cancer Center Research Institute)
- J. Luis Espinoza
(Kindai University Faculty of Medicine)
- Takahiro Kumode
(Kindai University Faculty of Medicine)
- Akira Tanimura
(Osaka University Graduate School of Medicine)
- Takafumi Yokota
(Osaka University Graduate School of Medicine)
- Kenji Oritani
(International University of Health and Welfare)
- Toshio Watanabe
(Graduate School of Humanities and Sciences, Nara Women’s University)
- Yuzuru Kanakura
(Osaka University Graduate School of Medicine)
- Itaru Matsumura
(Kindai University Faculty of Medicine)
Abstract
Mutated receptor tyrosine kinases (MT-RTKs) such as internal tandem duplication of FMS-like tyrosine kinase 3 (FLT3 ITD) and a point mutation KIT D816V are driver mutations for acute myeloid leukemia (AML). Clathrin assembly lymphoid myeloid leukemia protein (CALM) regulates intracellular transport of RTKs, however, the precise role for MT-RTKs remains elusive. We here show that CALM knock down leads to severely impaired FLT3 ITD- or KIT D814V-dependent cell growth compared to marginal influence on wild-type FLT3- or KIT-mediated cell growth. An antipsychotic drug chlorpromazine (CPZ) suppresses the growth of primary AML samples, and human CD34+CD38- AML cells including AML initiating cells with MT-RTKs in vitro and in vivo. Mechanistically, CPZ reduces CALM protein at post transcriptional level and perturbs the intracellular localization of MT-RTKs, thereby blocking their signaling. Our study presents a therapeutic strategy for AML with MT-RTKs by altering the intracellular localization of MT-RTKs using CPZ.
Suggested Citation
Shinya Rai & Hirokazu Tanaka & Mai Suzuki & J. Luis Espinoza & Takahiro Kumode & Akira Tanimura & Takafumi Yokota & Kenji Oritani & Toshio Watanabe & Yuzuru Kanakura & Itaru Matsumura, 2020.
"Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V,"
Nature Communications, Nature, vol. 11(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17666-8
DOI: 10.1038/s41467-020-17666-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17666-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.